The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of anti-PD-L1 antibody (atezolizumab) in grade 2 and 3 chondrosarcoma.
 
Mohamad Adham Salkeni
Research Funding - AstraZeneca/MedImmune (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Quintiles Inc. (Inst); Seagen (Inst); Takeda (Inst)
 
Anthony Paul Conley
Consulting or Advisory Role - Bayer; Deciphera; Deciphera; Genentech; Guidepoint Global; InhibRx; Medscape; Nektar; Novartis; OncLive; Schlesinger Associates
Research Funding - Bavarian Nordic (Inst); Ignyta (Inst); Iovance Biotherapeutics (Inst); MedImmune (Inst); NantHealth (Inst)
Travel, Accommodations, Expenses - Genentech
 
James Lin Chen
Consulting or Advisory Role - Syapse; Tempus
Speakers' Bureau - Foundation Medicine
Research Funding - Eisai
Patents, Royalties, Other Intellectual Property - MatchTX
 
Elizabeth J. Davis
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Deciphera
Speakers' Bureau - Physicans' Education Resource
Research Funding - Actuate Therapeutics (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); TopAlliance BioSciences Inc (Inst)
 
Melissa Amber Burgess
Consulting or Advisory Role - Rain Therapeutics
Research Funding - Merck
Travel, Accommodations, Expenses - SpringWorks Therapeutics
(OPTIONAL) Uncompensated Relationships - TRACON Pharma
 
Albiruni Ryan Abdul Razak
Consulting or Advisory Role - Adaptimmune; Bayer; GlaxoSmithKline; Inhibrx; Medison
Research Funding - Abbvie; Adaptimmune; Amgen; Blueprint Medicines; Bristol-Myers Squibb; Daiichi Sankyo; Deciphera; GlaxoSmithKline; Iterion Therapeutics; Karyopharm Therapeutics; MedImmune; Merck; Neoleukin Therapeutics; Pfizer; Rain Therapeutics; Roche/Genentech; Symphogen
Expert Testimony - Medison
 
Nancy Moore
No Relationships to Disclose
 
Katherine V. Ferry-Galow
No Relationships to Disclose
 
Kristin K. Fino
No Relationships to Disclose
 
King Leung Fung
No Relationships to Disclose
 
Ralph E. Parchment
Employment - Leidos Biomedical Research
Stock and Other Ownership Interests - Inovio Pharmaceuticals; Leidos; SciTech Development LLC
Patents, Royalties, Other Intellectual Property - Cambridge University Press for The Biological Basis of Cancer; Named Inventor on US Patent 9,644,037; Named inventor on US Patent US8709379 B2
 
Jared C. Foster
No Relationships to Disclose
 
Christina Rosenberger
No Relationships to Disclose
 
Geraldine Helen O'Sullivan Coyne
No Relationships to Disclose
 
Naoko Takebe
No Relationships to Disclose
 
Elad Sharon
No Relationships to Disclose
 
James H. Doroshow
No Relationships to Disclose
 
Alice P. Chen
(OPTIONAL) Uncompensated Relationships - Frontiers in Medicine